ProShare Advisors
ACOR

ProShare Advisors’s Acorda Therapeutics ACOR Stock Holding History

ProShare Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-161
Closed -$56K – 1811
2019
Q3 		$56K Sell
161
-4
-2% -$2.17K ﹤0.01% 1594
2019
Q2 		$152K Sell
165
-19
-10% -$23.3K ﹤0.01% 1488
2019
Q1 		$294K Buy
184
+2
+1% +$3.6K ﹤0.01% 1270
2018
Q4 		$340K Sell
182
-32
-15% -$69.6K ﹤0.01% 1090
2018
Q3 		$505K Sell
214
-11
-5% -$34.1K ﹤0.01% 1094
2018
Q2 		$776K Sell
225
-13
-5% -$39.8K 0.01% 930
2018
Q1 		$677K Sell
238
-37
-13% -$111K ﹤0.01% 980
2017
Q4 		$709K Buy
275
+24
+10% +$68.2K ﹤0.01% 978
2017
Q3 		$713K Buy
251
+14
+6% +$36.9K 0.01% 828
2017
Q2 		$561K Sell
237
-20
-8% -$39.6K 0.01% 917
2017
Q1 		$647K Sell
257
-63
-20% -$181K 0.01% 912
2016
Q4 		$722K Buy
320
+35
+12% +$83.2K 0.01% 921
2016
Q3 		$715K Sell
285
-53
-16% -$158K 0.01% 800
2016
Q2 		$1.03M Buy
338
+3
+0.9% +$9.76K 0.01% 707
2016
Q1 		$1.06M Sell
335
-15
-4% -$62.3K 0.01% 680
2015
Q4 		$1.8M Buy
350
+37
+12% +$162K 0.02% 542
2015
Q3 		$996K Sell
313
-23
-7% -$89.2K 0.01% 670
2015
Q2 		$1.34M Sell
336
-26
-7% -$100K 0.02% 646
2015
Q1 		$1.45M Buy
362
+47
+15% +$215K 0.02% 666
2014
Q4 		$1.54M Sell
315
-11
-3% -$47.2K 0.02% 650
2014
Q3 		$1.33M Sell
326
-81
-20% -$304K 0.02% 953
2014
Q2 		$1.65M Sell
407
-218
-35% -$889K 0.02% 899
2014
Q1 		$2.84M Buy
625
+435
+229% +$1.76M 0.04% 540
2013
Q4 		$667K Sell
190
-159
-46% -$620K 0.01% 1037
2013
Q3 		$1.44M Buy
349
+46
+15% +$198K 0.03% 606
2013
Q2 		$1.2M Buy
+303
New +$1.25M 0.02% 734

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ProShare Advisors's ACOR Position: Q4 2019 in Review

ProShare Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 161 shares — an estimated $56K sold.

ProShare Advisors first reported a position in ACOR in Q2 2013 and held it in 26 quarters. The position peaked at $2.84M in Q1 2014. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • ProShare Advisors reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • ProShare Advisors sold 161 Acorda Therapeutics shares in Q4 2019, an estimated $56K.
  • ProShare Advisors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 26 quarters.
  • ProShare Advisors's Acorda Therapeutics position peaked at $2.84M in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.